In mid-2022, Agios Pharmaceuticals (NASDAQ:AGIO) was mentioned on this blog as kind of a special situation. It was explained that the company was roughly available at its cash value. Some of the value described seems to have materialized now and the stock increased from $17.60 to around $33.00. Because of many other excellent opportunities, this might be a good moment to cash in and realize the profit of almost 90% - congratulations!
Are you investing in the stock market? Are you consistently looking for new potential ideas to make some extra bucks? If yes, this blog may be something for you. In a concise way, you’ll find ideas of potentially under- or overvalued stocks. For further information, see the first blog entry titled "What is this all about?"
Nothing on here is an investment advice — do your own due diligence.
No comments:
Post a Comment